Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
PLoS One ; 16(12): e0261092, 2021.
Article in English | MEDLINE | ID: mdl-34905577

ABSTRACT

BACKGROUND: To determine the prevalence of food allergy (FA) and factors associated with these occurrences in different populations from different regions. MATERIALS AND METHODS: The literature search will be conducted via Pubmed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Vip and Wanfang databases. Ratio rate (RR), odds ratio (OR) and 95% confidence intervals (CIs) will be adopted to evaluate prevalence and factors for FA in different populations from different regions. When the heterogeneity is small (I2<50%), the fixed effect model will be analyzed, otherwise, random effects model analysis will be performed. When the heterogeneity is large (I2≥50%), Meta regression will be used to explore the sources of inter-study heterogeneity. When the heterogeneity is large (I2≥50%) and the results are statistically significant (P<0.05), subgroup analysis will be analyzed based on age, gender, race/region, literature quality and other factors. Funnel plots will be used to reflect reporting bias and the Begg's test will be used to test the symmetry of the funnel plots. When publication bias occurs, "cut-and-fill" method will be adopted to adjust publication bias. And sensitivity analysis will be performed for all outcome indicators. DISCUSSION: This meta-analysis will evaluate the prevalence of FA and factors associated with these occurrences in different populations from different regions on the basis of existing evidences. Our study may be crucial to analyze similarities and differences regarding FA between different individuals from diverse regions and eventually define preventive or diagnostic approaches specifically tailored to certain populations and regions. SYSTEMATIC REVIEW REGISTRATION: OSF registration number: 10.17605/OSF.IO/VQXU9.


Subject(s)
Food Hypersensitivity/epidemiology , Prevalence , China/epidemiology , Humans , Meta-Analysis as Topic , Research Design , Systematic Reviews as Topic
2.
Cell Biochem Funct ; 38(4): 480-489, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31989663

ABSTRACT

This study investigated the role of interleukin (IL)-9 and IL-10 in the pathogenesis of chronic spontaneous urticaria (CSU). Autologous serum skin test and histamine release test were performed in CSU patients and normal subjects. Kunming mice were used to develop a mouse model for CSU. We induced IL-9 overexpression, IL-10 overexpression, and JAK/STAT pathway inhibition as well as a combination of all three conditions in CSU and control mice. Eosinophils in the skin tissues, inflammatory cytokine expression, and distribution of T lymphocyte subsets in peripheral blood of mice were detected. Expression patterns of IL-9, IL-10, STAT3, JAK2, and INF-γ in clinical samples and mice were detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. The positive rate of autologous serum skin test and the histamine release rate of CSU patients, compared with normal subjects, were apparently elevated. Compared with controls, mice with CSU experienced longer duration and higher frequency of pruritus and demonstrated enhanced levels of CD8+ , the ratio of CD4+ /CD8+ , number of eosinophils, and inflammatory cytokine expression in serum as well as activated JAK/STAT signalling pathway; at the same time, levels of CD4+ and INF-γ were reduced. This trend was found in CSU mice overexpressing IL-9 and IL-10 when compared with the CSU mice without treatment. In contrast, JAK/STAT inhibition reversed the above trend. Overall, our study suggests that IL-9 and IL-10 contribute to CSU development via activation of the JAK/STAT signalling pathway.


Subject(s)
Chronic Urticaria/immunology , Interleukin-10/immunology , Interleukin-9/immunology , Janus Kinase 2/immunology , STAT3 Transcription Factor/immunology , Signal Transduction/immunology , Adult , Animals , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Chronic Urticaria/pathology , Female , Humans , Interferon-gamma , Male , Mice , Middle Aged
3.
Toxicology ; 411: 101-109, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30445054

ABSTRACT

A large number of studies have evidenced that developmental neurotoxicity induced by lead (Pb) is related to oxidative injury. Furthermore, recent studies have found that developmental Pb exposure can induce neurodegeneration in old age. Because of the common presence of Pb in the environment, humans are exposed to this metal throughout their lifetime. However, few studies have explored the changes in lifespan profiles of neurotoxicity, as well as oxidative stress following lifetime Pb exposure. In the present study, rats were exposed to lead acetate from their embryonic stage to old age. Dynamic changes in neurodegeneration, oxidative stress, and endoplasmic reticulum (ER) stress in the brains at postnatal week 3 (PNW3, weaning), 41 weeks (PNW41, adulthood) and 70 weeks (PNW70, old age) were investigated. Pb exposure resulted in neurodegeneration with decreased neuronal densities and brain volumes in PNW3 and PNW70 rats; however, no significant changes occurred in PNW41 rats based on thionine stain analysis and magnetic resonance imaging (MRI) scans. Expression of the ER stress protein glucose-regulated protein 78 (GRP78) increased in Pb-exposed rats, which was associated with high levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in rat brains after Pb exposure in PNW3 and PNW70 rats. Our findings suggested that lifetime Pb exposure induced neurodegenerative injuries that began to occur in infancy, were relieved in adulthood, but intensified in old age. The critical periods for prevention or intervention in neurodegenerative diseases induced by Pb exposure occurred in early life.


Subject(s)
Brain/pathology , Lead Poisoning, Nervous System/pathology , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/pathology , Oxidative Stress/drug effects , 8-Hydroxy-2'-Deoxyguanosine , Aging , Animals , Brain/diagnostic imaging , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/metabolism , Endoplasmic Reticulum Chaperone BiP , Endoplasmic Reticulum Stress/drug effects , Female , Gene Expression Regulation/drug effects , Lead/blood , Lead/metabolism , Lead Poisoning, Nervous System/diagnostic imaging , Magnetic Resonance Imaging , Male , Neurodegenerative Diseases/diagnostic imaging , Neurons/pathology , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Rats , Rats, Sprague-Dawley
4.
Mikrochim Acta ; 185(2): 136, 2018 01 26.
Article in English | MEDLINE | ID: mdl-29594442

ABSTRACT

The authors describe a chemiluminescence (CL)-based assay for the determination of bromate. The method is based on the use of a solution of carbon quantum dots (CQDs) and sulfite. Strong CL (peak at 490 nm) is observed when bromate is injected into the solution. The CL increases linearly in the 0.3 to 10 µmol L-1 bromate concentration range, giving a 0.1 µmol L-1 limit of detection (at an S/N ratio of 3). A possible CL mechanism is suggested that involves a redox reaction between the CQDs, bromate and sulfite in the acidic medium. This leads to the formation of hole-injected and electron-injected CQDs. Radiative recombination of oxidant-injected holes and electrons in the CQDs accounts for the occurrence of CL. This mechanism contradicts the previous assumption that the transfer of energy occurs from SO2* to the CQDs. Although nitrite may interfere in the determination of bromate, its effect can be eliminated by adding sulfamic acid. The assay is sensitive and represents a new tool for the determination of bromate, which is a carcinogen. Graphical abstract Under acidic condition, carbon quantum dots (CQDs) can react with sulfite and bromate transforming to hole-injected CQDs (CQDs•-) and electron-injected CQDs (CQDs•+), respectively. Thereafter, strong chemiluminescence (490 nm) aroused from the radiative electron-hole annihilation between CQDs•- and CQDs•+.

5.
Environ Toxicol Pharmacol ; 44: 84-92, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27131751

ABSTRACT

Based on how the silent information regulator 2 homolog 1 (SIRT1) regulates the cyclic AMP response element binding protein (CREB), which is the molecular switch of long-term memory that maintains cognitive function, it is postulated that the impact of lead (Pb) on SIRT1 is one of the mechanisms leading to Pb-induced cognitive and learning deficits. Hence, the purpose of this study was to investigate the effect of Pb exposure on the expression of SIRT1, and the reversion effect of resveratrol, which is an activator of SIRT1. We examined the effects of maternal rat ingestion of Pb in drinking water during gestation and lactation on the expression of SIRT1 and CREB in the hippocampus of their offspring at postnatal week 3 (PNW3) and 52 (PNW52), and then reexamined these effects in offspring after intragastric administration of resveratrol for 4 weeks. Pb exposure decreased SIRT1 and CREB phosphorylation in a dose-dependent manner in the rat hippocampus at both PNW3 and 52, and resveratrol reversed those losses. These results indicated that SIRT1 might be a novel target to prevent Pb neurotoxicity.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Hippocampus/drug effects , Lead/toxicity , Sirtuin 1/metabolism , Animals , Cyclic AMP Response Element-Binding Protein/genetics , Female , Hippocampus/metabolism , Male , Maternal-Fetal Exchange , Neuroprotective Agents/pharmacology , Phosphorylation/drug effects , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Resveratrol , Sirtuin 1/genetics , Stilbenes/pharmacology
6.
Ann Occup Hyg ; 53(4): 341-51, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19357318

ABSTRACT

BACKGROUND: We carried out animal experiments based on the orthogonal design L(8)(2(7)) setting seven factors with two different levels of each and 10 groups of rats. The nutrients tested were tyrosine, glycine, methionine, taurine, ascorbic acid, thiamine and zinc. OBJECTIVES: The objective of this study was to explore the optimal combinations of nutrients for prevention or amelioration of lead-induced learning and memory impairment. METHODS: Rats were supplemented with nutrients by gavage once a day in two experiments: one was simultaneous nutrient supplementation with lead acetate administration (800 mg l(-1)) for 8 weeks (prophylactic supplementation) and the other was nutrient supplementation for 4 weeks after the cessation of 4 weeks of lead administration (remedial supplementation). Morris water maze was initiated at ninth week. Rats were terminated for assays of levels of Pb in blood, activities of superoxide dismutase (SOD) and nitric oxide synthase (NOS) in hippocampus, levels of nitric oxide (NO) in hippocampus and expressions of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and cyclic adenosine monophosphate (cAMP) response element-binding protein messenger RNA in hippocampus. RESULTS: Results showed that in prophylactic supplementation, methionine, taurine, zinc, ascorbic acid and glycine were the effective preventive factors for decreasing prolonged escape latency, increasing SOD and NOS activities and NO levels in the hippocampus, respectively. On the other hand, in remedial supplementation, taurine was the effective factor for reversing Pb-induced decrease in activities of SOD, NOS and levels of NO. CONCLUSIONS: In conclusion, the optimum combinations of nutrients appear to be methionine, taurine, zinc, ascorbic acid and glycine for the prevention of learning and memory impairment, while taurine and thiamine appear to be the effective factors for reversing Pb neurotoxicity.


Subject(s)
Food , Lead Poisoning/prevention & control , Learning Disabilities/prevention & control , Memory Disorders/prevention & control , Animals , Antioxidants/analysis , Ascorbic Acid/therapeutic use , Glycine/therapeutic use , Hippocampus/chemistry , Lead Poisoning/drug therapy , Lead Poisoning/psychology , Lead Poisoning, Nervous System/drug therapy , Lead Poisoning, Nervous System/prevention & control , Learning Disabilities/drug therapy , Male , Maze Learning/drug effects , Memory Disorders/drug therapy , Methionine/therapeutic use , Models, Animal , Organometallic Compounds , Rats , Rats, Sprague-Dawley , Taurine/therapeutic use , Thiamine/therapeutic use , Tyrosine/therapeutic use , Zinc/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...